Trained scent dogs can identify presence of thyroid cancer in urine
the ONA take:
A trained scent dog is able to accurately identify presence of thyroid cancer in urine samples, a recent study presented at The Endocrine Society meeting in San Diego has found.
Donald Bodenner, MD, PhD, of the University of Arkansas for Medical Sciences and colleagues acquired urine samples from 34 patients before they went on to have a biopsy for suspicious thyroid nodules Previously, Bodenner’s co-author, Arny Ferrando, PhD, scent-trained a rescued German Shepherd-mix to recognize the smell of cancer in thyroid tissue, awarding the dog for identifying cancer samples while turning away from benign ones.
When presented with the samples, the dog was able to match final surgical pathology in 30 of the 34 patients, resulting in a true-positive rate of 86.7 percent as well as a true-negative rate of 89.5 percent.
The researchers plan to expand their program in collaboration with the Auburn University College of Veterinary Medicine in order to train two bomb-sniffing dogs to also detect thyroid cancer.
A trained scent dog is able to accurately identify presence of thyroid cancer in urine samples.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Prolactin Expression May Indicate Better Prognosis for Patients With TNBC
- Caregiver Mastery Linked to Patient Survival in Glioblastoma
- Treatment Facility Volume Associated With Mortality Risk in Multiple Myeloma
- Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|